Close Menu

NEW YORK (GenomeWeb) – OneOme announced today that it has signed an agreement to offer its RightMed pharmacogenomic test in Canada through medication management firm ProZed Pharmacy Solutions.

Under the terms of the deal, OneOme's PCR-based RightMed test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be exclusively available to ProZed customers at Northern Shores Pharmacy in North Bay, Ontario.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.